Canada's Healwell AI fiscal 2025 revenue jumps 427%

Overview

• Canada healthcare AI firm's fiscal 2025 revenue grew 427% yr/yr to record levels

• Company posted first full yr of positive Adjusted EBITDA after prior yr loss

• Healwell transitioned to pure-play AI and software, generating C$9.7 mln in divestment proceeds

Outlook

• Healwell targets exit run-rate Adjusted EBITDA margin of about 10% in 2026

• Company aims to scale globally and deepen AI adoption across its installed base in 2026

• Healwell expects operating leverage as Orion Health integration synergies are realized and AI deployments scale

Result Drivers

• ORION HEALTH ACQUISITION - Co said acquisition of Orion Health contributed significantly to revenue growth in Q4-2025

• ENTERPRISE AI DEPLOYMENTS - Co cited scaling enterprise AI deployments, including government and U.S. HIE contracts, as key to platform adoption and revenue gains

• STRATEGIC DIVESTMENTS - Transition to pure-play AI and software business and C$9.7 mln in divestment proceeds supported focus and balance sheet

Company press release: ID:nNFC98Xfc7

Key Details

Analyst Coverage

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 10 "strong buy" or "buy", no "hold" and no "sell" or "strong sell"

• The average consensus recommendation for the advanced medical equipment & technology peer group is "buy"

• Wall Street's median 12-month price target for Healwell Al Inc is C$2.88, about 209.1% above its March 18 closing price of C$0.93

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.